Given that only CD8+ T cells are capable of recognizing antigens presented on major histocompatibility complex class I (MHC-I), which are present on all somatic cells, CD40L expression by CD8+ T cells could potentiate anticancer immune responses against CD40-expressing cancer cells. This evidence concerns the gene CD8A and cancer.